These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 9027366

  • 1. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.
    Zhuang SH, Schwartz GG, Cameron D, Burnstein KL.
    Mol Cell Endocrinol; 1997 Jan 03; 126(1):83-90. PubMed ID: 9027366
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1993 May 03; 132(5):1952-60. PubMed ID: 7682937
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.
    Yang ES, Maiorino CA, Roos BA, Knight SR, Burnstein KL.
    Mol Cell Endocrinol; 2002 Jan 15; 186(1):69-79. PubMed ID: 11850123
    [Abstract] [Full Text] [Related]

  • 10. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 11. Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31.
    Moffatt KA, Johannes WU, Hedlund TE, Miller GJ.
    Cancer Res; 2001 Oct 01; 61(19):7122-9. PubMed ID: 11585744
    [Abstract] [Full Text] [Related]

  • 12. Resistance of HBL100 human breast epithelial cells to vitamin D action.
    Agadir A, Lazzaro G, Zheng Y, Zhang XK, Mehta R.
    Carcinogenesis; 1999 Apr 01; 20(4):577-82. PubMed ID: 10223184
    [Abstract] [Full Text] [Related]

  • 13. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA, Welsh J.
    J Steroid Biochem Mol Biol; 2003 Feb 01; 84(2-3):149-57. PubMed ID: 12710998
    [Abstract] [Full Text] [Related]

  • 14. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ, Gombart AF, Kwok SH, Park S, Koeffler HP.
    Oncogene; 2000 Oct 19; 19(44):5091-7. PubMed ID: 11042697
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.
    Hedlund TE, Moffatt KA, Miller GJ.
    Endocrinology; 1996 May 19; 137(5):1554-61. PubMed ID: 8612485
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.
    Lambert JR, Kelly JA, Shim M, Huffer WE, Nordeen SK, Baek SJ, Eling TE, Lucia MS.
    J Cell Physiol; 2006 Sep 19; 208(3):566-74. PubMed ID: 16741990
    [Abstract] [Full Text] [Related]

  • 19. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 19; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Feb 19; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.